Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-23-009712

Options or other derivatives

  • EVP and COO acquired 112,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wolff Stefani · EVP and COO

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-02-14 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +88,900 88,900 D
2023-02-14 Grant or award : show line 2 in the form Restricted Stock Units +24,000 24,000 D
Loading xslF345X03/doc4.xml…